Literature DB >> 32946878

Antibody-Mediated Protection against Staphylococcus aureus Dermonecrosis: Synergy of Toxin Neutralization and Neutrophil Recruitment.

Ching Yang1, Juan de Dios Ruiz-Rosado2, Frank H Robledo-Avila3, Zhaotao Li3, Ryan N Jennings4, Santiago Partida-Sanchez5, Christopher P Montgomery5.   

Abstract

The staphylococcal α-hemolysin is critical for the pathogenesis of Staphylococcus aureus skin and soft tissue infection. Vaccine and infection-elicited α-hemolysin-specific antibodies protect against S. aureus‒induced dermonecrosis, a key feature of skin and soft tissue infection. Many interactions between α-hemolysin and host cells have been identified that promote tissue damage and modulate immune responses, but the mechanisms by which protective adaptive responses cross talk with innate responses at the tissue level are not clear. Using an established mouse model of skin and soft tissue infection and a newly developed histopathologic scoring system, we observed pathologic correlates early after infection, predicting protection against dermonecrosis by anti-α-hemolysin antibody. Protection was characterized by robust neutrophilic inflammation and compartmentalization of bacteria into discrete abscesses, which led to the attenuation of dermonecrosis and enhancement of bacterial clearance later in the infection. The ultimate outcome of infection was driven by the recruitment of neutrophils within the first day after infection but not later. Antibody-mediated protection was dependent on toxin neutralization rather than on enhanced opsonophagocytic killing by neutrophils or protection against toxin-mediated neutrophil lysis. Together, these findings advance our understanding of the mechanisms by which the early synergism between antibody-mediated toxin neutralization and tissue-specific neutrophilic inflammation preserve tissue integrity during infection.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32946878      PMCID: PMC7960571          DOI: 10.1016/j.jid.2020.09.001

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

1.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

2.  ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin.

Authors:  Michael E Powers; Hwan Keun Kim; Yang Wang; Juliane Bubeck Wardenburg
Journal:  J Infect Dis       Date:  2012-04-02       Impact factor: 5.226

Review 3.  Pathogenesis of Staphylococcus aureus abscesses.

Authors:  Scott D Kobayashi; Natalia Malachowa; Frank R DeLeo
Journal:  Am J Pathol       Date:  2015-03-04       Impact factor: 4.307

4.  Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

Authors:  Vance G Fowler; Keith B Allen; Edson D Moreira; Moustafa Moustafa; Frank Isgro; Helen W Boucher; G Ralph Corey; Yehuda Carmeli; Robert Betts; Jonathan S Hartzel; Ivan S F Chan; Tessie B McNeely; Nicholas A Kartsonis; Dalya Guris; Matthew T Onorato; Steven S Smugar; Mark J DiNubile; Ajoke Sobanjo-ter Meulen
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

5.  Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for panton-valentine leukocidin?

Authors:  Christopher P Montgomery; Robert S Daum
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

6.  A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.

Authors:  Stephanie A Fritz; Kristin M Tiemann; Patrick G Hogan; Emma K Epplin; Marcela Rodriguez; Duha N Al-Zubeidi; Juliane Bubeck Wardenburg; David A Hunstad
Journal:  Clin Infect Dis       Date:  2013-02-27       Impact factor: 9.079

7.  Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia.

Authors:  Mark E Rupp; H Preston Holley; Jon Lutz; Peter V Dicpinigaitis; Christopher W Woods; Donald P Levine; Naomi Veney; Vance G Fowler
Journal:  Antimicrob Agents Chemother       Date:  2007-09-24       Impact factor: 5.191

Review 8.  Epidemiology and microbiology of skin and soft tissue infections.

Authors:  Silvano Esposito; Silvana Noviello; Sebastiano Leone
Journal:  Curr Opin Infect Dis       Date:  2016-04       Impact factor: 4.915

9.  Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination.

Authors:  Youhui Si; Fan Zhao; Pavani Beesetty; Daniela Weiskopf; Zhaotao Li; Qiaomu Tian; Maria-Luisa Alegre; Alessandro Sette; Anita S Chong; Christopher P Montgomery
Journal:  Sci Adv       Date:  2020-04-01       Impact factor: 14.136

10.  Importance of B Lymphocytes and the IgG-Binding Protein Sbi in Staphylococcus aureus Skin Infection.

Authors:  Fan Zhao; Anita S Chong; Christopher P Montgomery
Journal:  Pathogens       Date:  2016-01-27
View more
  3 in total

1.  Antibiotic Treatment of Staphylococcus aureus Infection Inhibits the Development of Protective Immunity.

Authors:  Maureen Kleinhenz; Pavani Beesetty; Ching Yang; Zhaotao Li; Christopher P Montgomery
Journal:  Antimicrob Agents Chemother       Date:  2022-03-10       Impact factor: 5.938

2.  Tissue specificity drives protective immunity against Staphylococcus aureus infection.

Authors:  Pavani Beesetty; Youhui Si; Zhaotao Li; Ching Yang; Fan Zhao; Anita S Chong; Christopher P Montgomery
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

Review 3.  Evasion of Immunological Memory by S. aureus Infection: Implications for Vaccine Design.

Authors:  Omid Teymournejad; Christopher P Montgomery
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.